Clinical trial

St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Nalmefene

NCT03278886

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-07-03

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2018-07-03Date precision: day

Registry last updated2020-08-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionunresolved

Alcohol Useunresolved

Painunresolved

Interventions

Low dose naltrexoneDRUG

NalmefeneDRUG · verified · RxNorm: nalmefene

Sponsors & collaborators

Boston Medical Centerlead sponsor

National Institute on Alcohol Abuse and Alcoholism (NIAAA)collaborator

Mapped research locations

Saint PetersburgRussia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03278886 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.